一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Pharmaceuticals >>article
Pharmaceuticals

Pharmaceuticals

IF: 4.3
Download PDF

Dehydroepiandrosterone and Its Metabolite 5-Androstenediol: New Therapeutic Targets and Possibilities for Clinical Application.

Published:9 September 2024 DOI: 10.3390/ph17091186 PMID: 39338348
Tatiana A Fedotcheva,?Maria E Uspenskaya,?Darya N Ulchenko,?Nikolay L Shimanovsky

Abstract

Dehydroepiandrosterone and its sulfate are the most abundant steroids in humans. The metabolism of dehydroepiandrosterone can differ significantly depending on the organ or tissue and the subtype of steroid receptors expressed in it. For dehydroepiandrosterone, as a precursor of all steroid hormones, intracrine hormonal activity is inherent. This unique feature could be beneficial for the medicinal application, especially for the local treatment of various pathologies. At present, the clinical use of dehydroepiandrosterone is limited by its Intrarosa? (Quebec city, QC, Canada) prasterone) 6.5 mg vaginal suppositories for the treatment of vaginal atrophy and dyspareunia, while the dehydroepiandrosterone synthetic derivatives Triplex, BNN 27, and Fluasterone have the investigational status for the treatment of various diseases. Here, we discuss the molecular targets of dehydroepiandrosterone, which open future prospects to expand its indications for use. Dehydroepiandrosterone, as an oral drug, is surmised to have promise in the treatment of osteoporosis, cachexia, and sarcopenia, as does 10% unguent for skin and muscle regeneration. Also, 5-androstenediol, a metabolite of dehydroepiandrosterone, is a promising candidate for the treatment of acute radiation syndrome and as an immunostimulating agent during radiopharmaceutical therapy. The design and synthesis of new 5-androstenediol derivatives with increased bioavailability may lead to the appearance of highly effective cytoprotectors on the pharmaceutical market. The argumentations for new clinical applications of these steroids and novel insights into their mechanisms of action are discussed.

Substances (5)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Dehydroepiandrosterone 53-43-0 C19H28O2 692 suppliers $18.00-$2760.00
5-ANDROSTENEDIOL 25975-59-1 C18H28O2 26 suppliers Inquiry
Fluasterone 112859-71-9 C19H27FO 17 suppliers Inquiry
ApoTox-Glo Triplex Assay 12 suppliers Inquiry
Scattered blue BNN 3 suppliers Inquiry

Similar articles

IF:40.8

Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets.

Signal Transduction and Targeted Therapy Bei Wang,?Lujin Wu,etc Published: 26 February 2021
IF:72.5

5-Fluorouracil: mechanisms of action and clinical strategies

Nature Reviews Cancer Daniel B. Longley, D. Paul Harkin,etc Published: 1 May 2003
IF:13

Dehydroepiandrosterone (DHEA): hypes and hopes.

Drugs Krzysztof Rutkowski, Pawe? Sowa,etc Published: 1 July 2014
宜丰县| 本溪市| 长葛市| 贵南县| 庆安县| 西城区| 枝江市| 赞皇县| 通化县| 沁阳市| 镇雄县| 湖州市| 云南省| 天台县| 铜鼓县| 遵义市| 平谷区| 上犹县| 长顺县| 西平县| 祁阳县| 仙居县| 阿拉善左旗| 南乐县| 莲花县| 芦山县| 武平县| 海安县| 北安市| 二连浩特市| 三门峡市| 宁化县| 旅游| 秦安县| 永和县| 温宿县| 句容市| 安龙县| 本溪市| 毕节市| 凌云县|